Washington Capital Management’s ResMed RMD Stock Holding History

Washington Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,200	Closed	-$325K	–	114
2023 Q3	$325K	Buy	+2,200	New	+$398K	0.3%	97
2019 Q4	–	Sell	-3,000	Closed	-$405K	–	104
2019 Q3	$405K	Sell	3,000 -1,000	-25%	-$131K	0.4%	78
2019 Q2	$488K	Hold	4,000	–	–	0.55%	54
2019 Q1	$416K	Sell	4,000 -1,000	-20%	-$103K	0.47%	72
2018 Q4	$569K	Hold	5,000	–	–	0.66%	35
2018 Q3	$577K	Hold	5,000	–	–	0.55%	44
2018 Q2	$518K	Sell	5,000 -1,000	-17%	-$101K	0.53%	47
2018 Q1	$591K	Hold	6,000	–	–	0.59%	38
2017 Q4	$508K	Hold	6,000	–	–	0.51%	47
2017 Q3	$462K	Sell	6,000 -1,000	-14%	-$76.5K	0.49%	48
2017 Q2	$545K	Hold	7,000	–	–	0.61%	34
2017 Q1	$504K	Hold	7,000	–	–	0.58%	40
2016 Q4	$434K	Buy	+7,000	New	+$429K	0.53%	53

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Washington Capital Management's RMD Position: Q4 2023 in Review

Washington Capital Management sold out of ResMed (RMD) in Q4 2023, closing a stake of 2,200 shares — an estimated $325K sold.

Washington Capital Management first reported a position in RMD in Q4 2016 and held it in 13 quarters. The position peaked at $591K in Q1 2018. 688 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

Washington Capital Management reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
Washington Capital Management sold 2,200 ResMed shares in Q4 2023, an estimated $325K.
Washington Capital Management first reported a position in ResMed in Q4 2016 and held it in 13 quarters.
Washington Capital Management's ResMed position peaked at $591K in Q1 2018.
688 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Washington Capital Management's 13F filing for Q4 2023, filed 19 Jan 2024.